70P Hypofractionated radiotherapy in combination with PD-1 inhibitors, GM-CSF and thymosin α1 in advanced relapsed metastatic solid tumors: An interim analysis of a single-arm phase II multicenter prospective clinical study.
Saved in:
| Title: | 70P Hypofractionated radiotherapy in combination with PD-1 inhibitors, GM-CSF and thymosin α1 in advanced relapsed metastatic solid tumors: An interim analysis of a single-arm phase II multicenter prospective clinical study. |
|---|---|
| Authors: | Yu, J.1 (AUTHOR), Yin, L.1 (AUTHOR), Wang, Q.2 (AUTHOR), Liu, J.1 (AUTHOR), Zhang, L.3 (AUTHOR), Ye, H.4 (AUTHOR), Xia, J.5 (AUTHOR), Xia, Y.6 (AUTHOR), Wu, J.1 (AUTHOR), Wang, W.7 (AUTHOR), Yang, Y.8 (AUTHOR), Zong, D.1 (AUTHOR), Hong, J.9 (AUTHOR), Wang, L.1 (AUTHOR), He, X.1 (AUTHOR) |
| Source: | Annals of Oncology. 2024 Supplement 4, Vol. 35, pS1431-S1431. 1p. |
| Database: | Academic Search Ultimate |
| ISSN: | 09237534 |
|---|---|
| DOI: | 10.1016/j.annonc.2024.10.091 |
